Merck Takes Patient-Directed Approach to Bring Innovation to the Treatment of Rare Neuromuscular Disorder, Generalized Myasthenia Gravis
Business Wire India Cladribine capsules have the potential to be the first oral treatment for people living with rare, chronic…